X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (31) 31
index medicus (29) 29
aged (28) 28
female (28) 28
middle aged (27) 27
male (26) 26
oncology (25) 25
adult (22) 22
chemotherapy (21) 21
cancer (18) 18
medicine & public health (16) 16
treatment outcome (15) 15
retrospective studies (14) 14
surgical oncology (14) 14
gastric cancer (13) 13
antineoplastic combined chemotherapy protocols - therapeutic use (11) 11
stomach neoplasms - drug therapy (11) 11
drug combinations (10) 10
stomach cancer (10) 10
care and treatment (9) 9
cisplatin (9) 9
fluorouracil (9) 9
gastroenterology & hepatology (9) 9
oxaliplatin (9) 9
s-1 (9) 9
stomach neoplasms - pathology (9) 9
antineoplastic combined chemotherapy protocols - adverse effects (8) 8
cisplatin - administration & dosage (8) 8
fluorouracil - administration & dosage (8) 8
radiotherapy (8) 8
aged, 80 and over (7) 7
cancer patients (7) 7
cancer research (7) 7
disease-free survival (7) 7
drug administration schedule (7) 7
gastroenterology (7) 7
research (7) 7
supportive care (7) 7
trial (7) 7
5-fluorouracil (6) 6
adenocarcinoma - drug therapy (6) 6
camptothecin - administration & dosage (6) 6
camptothecin - analogs & derivatives (6) 6
internal medicine (6) 6
japan (6) 6
oncology, experimental (6) 6
oxonic acid - administration & dosage (6) 6
pathology (6) 6
survival analysis (6) 6
survival rate (6) 6
tegafur - administration & dosage (6) 6
therapy (6) 6
anemia (5) 5
antimitotic agents (5) 5
antineoplastic agents (5) 5
antineoplastic agents - administration & dosage (5) 5
cell lung-cancer (5) 5
clinical study (5) 5
colorectal cancer (5) 5
colorectal neoplasms - drug therapy (5) 5
deoxycytidine - analogs & derivatives (5) 5
irinotecan (5) 5
metastasis (5) 5
methotrexate (5) 5
neoplasm staging (5) 5
neutropenia (5) 5
oxonic acid - adverse effects (5) 5
oxonic acid - therapeutic use (5) 5
side effects (5) 5
survival (5) 5
tegafur - adverse effects (5) 5
tegafur - therapeutic use (5) 5
abdominal surgery (4) 4
adenocarcinoma - mortality (4) 4
adenocarcinoma - pathology (4) 4
analysis (4) 4
antimetabolites, antineoplastic - therapeutic use (4) 4
antineoplastic agents - adverse effects (4) 4
antineoplastic agents - therapeutic use (4) 4
antineoplastic combined chemotherapy protocols - administration & dosage (4) 4
chemotherapy, adjuvant (4) 4
clinical trials (4) 4
colorectal neoplasms - mortality (4) 4
combination (4) 4
deoxycytidine - therapeutic use (4) 4
dermatology (4) 4
diagnostic radiology (4) 4
efficacy (4) 4
esophageal cancer (4) 4
leucovorin (4) 4
leucovorin - administration & dosage (4) 4
mic (4) 4
pancreatic cancer (4) 4
pancreatic neoplasms - drug therapy (4) 4
patients (4) 4
peritoneal neoplasms - secondary (4) 4
phase-iii trial (4) 4
randomized-trial (4) 4
safety (4) 4
stomach neoplasms - mortality (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gastric Cancer, ISSN 1436-3291, 1/2018, Volume 21, Issue 1, pp. 84 - 95
Journal Article
International Journal of Clinical Oncology, ISSN 1341-9625, 12/2018, Volume 23, Issue 6, pp. 1084 - 1089
Although oxaliplatin 130 mg/m2 every 3 weeks was approved for advanced gastric cancer in Japan, data regarding S-1 plus oxaliplatin 130 mg/m2 (SOX130) are... 
Oxaliplatin | Medicine & Public Health | Japanese study | Oncology | Cancer Research | Surgical Oncology | Advanced gastric cancer | SOX
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 8/2017, Volume 73, Issue 8, pp. 1033 - 1039
Journal Article
The Tohoku Journal of Experimental Medicine, ISSN 0040-8727, 2017, Volume 243, Issue 3, pp. 195 - 203
Patient falls are common adverse medical events in hospitals. The objectives of this study were to clarify the factors of patient falls at hospitalization or... 
risk assessment | falls | inpatients | hospital | safety | Falls | Inpatients | Hospital | Safety | Risk assessment | MEDICINE, RESEARCH & EXPERIMENTAL | MEDICINE, GENERAL & INTERNAL | COST | OLDER-ADULTS | DRUGS
Journal Article
International Journal of Clinical Oncology, ISSN 1341-9625, 2/2013, Volume 18, Issue 1, pp. 10 - 16
Journal Article
Gastric Cancer, ISSN 1436-3291, 12/2009, Volume 12, Issue 4, pp. 206 - 211
Journal Article
Cancer Science, ISSN 1347-9032, 08/2013, Volume 104, Issue 8, pp. 1039 - 1044
Journal Article
Gastric Cancer, ISSN 1436-3291, 3/2019, Volume 22, Issue 2, pp. 344 - 354
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 2/2012, Volume 69, Issue 2, pp. 439 - 446
The primary objective of this Phase I study was to assess the safety and tolerability of the vascular endothelial growth factor signalling inhibitor cediranib... 
Phase I | Medicine & Public Health | Cancer Research | Oncology | Pharmacology/Toxicology | VEGF signalling | Gastric cancer | Japanese | Cediranib | 1ST-LINE TREATMENT | BEVACIZUMAB | METASTATIC COLORECTAL-CANCER | CHEMOTHERAPY | CELL LUNG-CANCER | SUPPORTIVE CARE | ONCOLOGY | TYROSINE KINASE INHIBITOR | PHARMACOLOGY & PHARMACY | AZD2171 | INFUSIONAL 5-FLUOROURACIL | ENDOTHELIAL GROWTH-FACTOR | Hyponatremia - chemically induced | Stomach Neoplasms - ethnology | Cisplatin - pharmacokinetics | Area Under Curve | Capecitabine | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Quinazolines - pharmacokinetics | Stomach Neoplasms - metabolism | Male | Metabolic Clearance Rate | Fatigue - chemically induced | Cisplatin - administration & dosage | Deoxycytidine - pharmacokinetics | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Adult | Deoxycytidine - adverse effects | Female | Quinazolines - administration & dosage | Oxonic Acid - pharmacokinetics | Neutropenia - chemically induced | Drug Administration Schedule | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Japan | Tegafur - adverse effects | Appetite - drug effects | Treatment Outcome | Oxonic Acid - administration & dosage | Stomach Neoplasms - drug therapy | Tegafur - pharmacokinetics | Oxonic Acid - adverse effects | Asian Continental Ancestry Group | Tumor Burden - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quinazolines - adverse effects | Cisplatin - adverse effects | Tegafur - administration & dosage | Aged | Fluorouracil - pharmacokinetics | Deoxycytidine - analogs & derivatives | Antimitotic agents | Medical colleges | Chemotherapy | Oncology, Experimental | Research | Antineoplastic agents | Vascular endothelial growth factor | Stomach cancer | Cancer | Endothelium | Index Medicus
Journal Article
Gastric Cancer, ISSN 1436-3291, 11/2010, Volume 13, Issue 4, pp. 245 - 250
Journal Article
International Journal of Clinical Oncology, ISSN 1341-9625, 8/2012, Volume 17, Issue 4, pp. 361 - 366
Journal Article
International Journal of Clinical Oncology, ISSN 1341-9625, 4/2013, Volume 18, Issue 2, pp. 279 - 284
Journal Article
Journal Article